X

About this post

Source
Author
Date
7:00 AM | February 12, 2013
Language
English
Categories
URL
Link to this page


This article is the second in a series by venture capitalist Standish Fleming looking at whether the strategy of acquiring molecules from Small Biotech can satisfy Big Pharma’s need for a sustainable supply of new products. The first article in the series outlined the topic. This second article delves more in depth into the source [...]

Tags

Comments

Log in to leave a comment